What is the dosage of Belsomra?

Belsomra is available in 4 dosages, including 10 mg Tab, 15 mg Tab, 20 mg Tab and 5 mg Tab

What does Belsomra treat?

Belsomra treats Sleep Initiation and Maintenance Disorders

What is Belsomra made of?

Belsomra contains suvorexant which is a Orexin Receptor Antagonist

How is Belsomra administered?

Belsomra is administered as a Oral Pill

What is Belsomra mechanism of action?

Belsomra mechanism of action is Cytochrome P450 3A Inhibitors, Orexin Receptor Antagonists or P-Glycoprotein Inhibitors

Dosage & Administration Drug label Samples Prior authorization Financial assistance

Patient education

Belsomra

(suvorexant)

suvorexant 10 MG Oral Tablet [Belsomra]suvorexant 15 MG Oral Tablet [Belsomra]

View 2 more

NO BLACK BOX WARNING

Dosage & administration

* Use the lowest dose effective for the patient .
* Recommended dose is 10 mg, no more than once per night taken within 30 minutes of going to bed, with at least 7 hours remaining before the planned time of awakening. If the 10 mg dose is well-tolerated but not effective, the dose can be increased, not to exceed 20 mg once daily .
* Time to effect may be delayed if taken with or soon after a meal .

Belsomra prescribing information

Have more Belsomra questions?

Submit MSL Request

Learn More

Need to report a Belsomra issue?

ONLINE FORMReport adverse event

Learn More

samples

Request Belsomra samples

Online Sample Form

Learn More

prior authorization

Belsomra Prior authorization resources

NOT PROVIDED BY BRANDComplete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

NOT PROVIDED BY BRANDCoverage Authorization Appeals

Learn More

Benefits investigation

NOT PROVIDED BY BRANDBenefits investigation resources

Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRANDReimbursement help (FRM) resources

Learn More

financial assistance

Belsomra Financial assistance options

Co-pay savings program

commercial only

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Belsomra Patient education

Getting started on Belsomra

NOT PROVIDED BY BRANDInstructions For Use - Insomnia

Patient toolkit

About Belsomra

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Learn More

Can't find what you're looking for?

Our trained staff can help you:

Please note:

Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
Samples are provided at the discretion of the brand.
We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.

Belsomra

Dosage & administration

Most viewed Belsomra resources

drug label

Belsomra prescribing information

Have more Belsomra questions?

Need to report a Belsomra issue?

samples

Request Belsomra samples

Is my patient elegible for Belsomra samples?

How do I find out who my Belsomra rep is?

prior authorization

Belsomra Prior authorization resources

Benefits investigation

Reimbursement help (FRM)

financial assistance

Belsomra Financial assistance options

Co-pay savings program

Overview

Patient benefit

Patient eligibility

How to sign up

Bridge program

Overview

Patient benefit

Patient eligibility

How to sign up

Foundation programs

Overview

Patient benefit

Patient eligibility

How to sign up

patient education

Belsomra Patient education

Getting started on Belsomra

Patient toolkit

Can't find what you're looking for?